Warszawski Uniwersytet Medyczny

Escilab Sp, Zo.o.

Bio Research Project Psa

Instytut Farmaceutyczny

Katarzyna Koziak

Oliwia Zegrocka-Stendel

Malgorzata Dutkiewicz

Grzegorz Grynkiewicz

Kamil Jatczak

Marta Laszcz

Mariusz Marek Gruza

Piotr Cmoch

Krzysztof Bojakowski

Magdalena Kowalewska

Dorota Maciejko

Iwona Grabowska

Katarzyna Filip

Barbara Zyzynska-Granica

Slawomir Filipek

Szymon Niewieczerzal

Bartosz Trzaskowski

Piotr Krzeczynski

Elzbieta Kaczmarek

Magdalena Winiarska

The invention relates to a 7-aminocephalosporanic acid derivative, Cefazolin, for use as an inhibitor of IL-15 and IL-2 receptors in the prevention and treatment of diseases related to IL-15 and IL-2 overproduction.

7-aminocephalosporanic acid derivative as inhibitor of IL15 and IL-2 activity

The present invention relates to an oral liquid composition comprising &#x3b2;-escin (beta-escin) and chokeberry fruit extract for use in treatment and prevention of conditions related to the increased acetaldehyde toxicity, such as veisalgia, alcohol poisoning, esophageal cancer, oropharyngolaryngeal cancer or a condition resulting from insufficient aldehyde dehydrogenase (ALDH) enzyme activity. Administration of the composition of the invention to a subject results in an increased metabolism of aldehydic substrates, in particular those originating from catabolism of alcohol and representing a hazard to humans due to their toxicity.

Oral compositions comprising beta-escin for reducing acetaldehyde toxicity

Described herein is compound including a protoescigenin derivative having pharmacological properties. Also described are a process of its preparation, and the use of such a compound as a medicament, especially for treating vascular disorders. A pharmaceutical composition comprising such compound is further described.

Protoescigenin derivative, process of its preparation, use of said compound and pharmaceutical composition comprising that compound

Growing community of inventors

Warsaw, Poland

Katarzyna Koziak